Suppr超能文献

药物研发中的高通量纯化:提升生产力至新高度。

High-Throughput Purification in Drug Discovery: Scaling New Heights of Productivity.

作者信息

Jones Mark, Goodyear Ross L

机构信息

Liverpool ChiroChem Ltd, The Heath Business & Technical Park, Runcorn, Cheshire WA7 4QX, U.K.

出版信息

ACS Med Chem Lett. 2023 May 31;14(7):916-919. doi: 10.1021/acsmedchemlett.3c00073. eCollection 2023 Jul 13.

Abstract

With the "low hanging fruit" of early drug discovery gone, pharmaceutical companies are increasingly turning to developing high-throughput synthetic platforms capable of greatly shortening the design-make-test cycle of new drugs. Purification has long been considered the bottleneck of this procedure; however, new technologies and systems are now being integrated into these high-throughput synthetic workflows, providing compounds of high purity capable of being used directly in biological screening.

摘要

随着早期药物发现的“低垂果实”逐渐减少,制药公司越来越多地转向开发能够大幅缩短新药设计-制造-测试周期的高通量合成平台。长期以来,纯化一直被视为这一过程的瓶颈;然而,新技术和系统现在正被整合到这些高通量合成工作流程中,从而提供能够直接用于生物筛选的高纯度化合物。

相似文献

1
High-Throughput Purification in Drug Discovery: Scaling New Heights of Productivity.药物研发中的高通量纯化:提升生产力至新高度。
ACS Med Chem Lett. 2023 May 31;14(7):916-919. doi: 10.1021/acsmedchemlett.3c00073. eCollection 2023 Jul 13.
4
High-throughput screening applied to drug synthesis process development.
Curr Opin Drug Discov Devel. 2000 Nov;3(6):743-9.
5
Novel trends in high-throughput screening.高通量筛选的新趋势。
Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21.

本文引用的文献

4
7
Synthesis of HDAC Inhibitor Libraries via Microscale Workflow.通过微尺度工作流程合成组蛋白去乙酰化酶(HDAC)抑制剂文库。
ACS Med Chem Lett. 2021 Feb 8;12(3):337-342. doi: 10.1021/acsmedchemlett.0c00596. eCollection 2021 Mar 11.
10
Artificial intelligence in drug discovery and development.人工智能在药物发现和开发中的应用。
Drug Discov Today. 2021 Jan;26(1):80-93. doi: 10.1016/j.drudis.2020.10.010. Epub 2020 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验